Insights from Academy of Managed Care Pharmacy (AMCP) Nexus 2023

Jessica Johnson, clinical consultant at Prime Therapeutics, shares some ways to avoid common fraud schemes

Perspectives High-Cost Therapy Profile: June 2024 Detailed information about Imetelstat Intravenous (IV) June 14, 2024 Oncology Imetelstat Intravenous (IV) Geron Proposed indications For the...

publications High-Cost Therapy Profile: February 2025 Revakinagene taroretcel Ocular implant | Neurotech Pharmaceuticals, Inc. Ophthalmology February 13, 2025 Proposed indications Macular...

publications 2024 Employer Market Insights Report June 28, 2024 Prime is pleased to present the seventh edition of the Employer Market Insights Report. Within this one-of-a-kind publication,...

Cover image for FDA Decisions Expected_February 2025 Drug pipeline for February 2025 Prime Therapeutics /fda-decisions-expected-february-2025 About Prime Therapeutics Prime Therapeutics logo Prime...

Publications High Cost Therapy Profile: October 2024 Eladocagene Exuparvovec October 15, 2024 Neurology Eladocagene Exuparvovec Intrapuraminal PTC Therapeutics, Inc. Proposed indications...

Event features Pat Gleason, AVP, health outcomes at Prime Therapeutics

Cover image for FDA Decisions Expected: November 2024 Drug pipeline for November 2024 Prime Therapeutics /fda-decisions-expected-november-2024 Prime Therapeutics’ FDA Decisions Expected outlines...

Tap into predictive analytics Our advanced analytics platform helps boost your clinical impact and drive down costs by delivering descriptive, diagnostic, predictive and prescriptive analytics....

Get support from the specialists in specialty We provide end-to-end support for patients taking specialty meds, helping them navigate the care journey. Breadcrumb Home Pharmacy Specialty Pharmacy...

Eyebrow High-Cost Therapy Profile: August 2024 Detailed information about intravenous (IV) linvoseltamab August 15, 2024 Oncology Linvoseltamab, intravenous (IV) Regeneron Pharmaceuticals ...

See our award-winning people & work Prime delivers unmatched care, groundbreaking research and industry-leading programs and services for health plans, employers and members. Breadcrumb Home Who we...

These new solutions reflect Prime's distinctive conflict-free approach to the prescription drug supply chain model.

Comprehensive PDL services With 40+ years of Medicaid pharmacy experience supporting over half the nation’s programs, we help states manage high drug costs and ensure members get the meds they...

Upgrade provides streamlined patient support and enhanced digital engagement for data-driven, holistic care

Event will feature David Lassen, chief clinical officer

Prime Careers Spotlight: November 2024 Check out our latest job openings. Together, we can help make health care better by helping clients and members navigate pharmacy benefits. Investment...

Cover image for Prime Therapeutics prioritizes patient-centered care, stays ahead of oncology trends Prime simplifies the cancer care pathway through innovative solutions that help manage complex...

PUBLICATIONS FDA Decisions Expected: April 2025 Your monthly synopsis of new drugs expected to hit the market March 14, 2025 Drug pipeline for April 2025 At Prime Therapeutics (Prime), we have...

Notice of Privacy Practices To allow a family member or agent to contact Prime on your behalf, please print, complete and return the release form below: Authorization for Release of Information |...

Breadcrumb Home Newsroom Custom Content Publications High-Cost Therapy Profile: September 2024 PUBLIcATIonS High-Cost Therapy Profile: September 2024 Detailed information about Intravenous (IV)...

Annual conference features presentations, panels, discussions and networking

Breadcrumb Home Newsroom Custom Content Prime Careers Spotlight Prime Careers Spotlight: July 2025 Prime Careers Spotlight: July 2025 Check out our latest job openings. Together, we can help make...

Dinesh Kandanchatha joined the organization July 1.

Managed Markets Insight & Technology (MMIT)

publications Drug Approvals: November 2024 Critical updates in an ever-changing environment This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a...

publications BiTEs and roadblocks June 25, 2025 Author: Simone Ndujiuba, PharmD, BCOP US Food and Drug Administration (FDA) has approved fourteen bispecific antibody drugs to treat a variety of...

Experience a different kind of PBM We’re your trusted, transparent partner that’s reimagining pharmacy solutions to deliver value back to those we serve and transforming our industry for the...

Expert Clinical Network Insights Metastatic Synovial Sarcoma October 21, 2024 Medication insights: afamitresgene autoleucel (Tecelra) The U.S. Food and Drug Administration (FDA) approved...

publications Carting away REMS and the impact on CAR T utilization August 19, 2025 Author: Simone Ndujiuba, PharmD, BCOP On June 26, 2025, the US Food and Drug Administration (FDA) removed...

Start a medication therapy management internship Get hands-on pharmacy experience and develop leadership, strategic-planning and patient care skills with our medication therapy management and...

Second annual report gives a transparent overview of Prime’s organizational makeup, highlights milestones along its journey

oncology insights Decoding Cancer: How Genetic and Genomic Testing Advance Treatment December 13, 2024 Scientists have made remarkable progress in understanding the thousands of genes inside our...

Latest edition of Prime Therapeutics Report spotlights seismic shift in how best to diagnose and manage transthyretin amyloid cardiomyopathy (ATTR-CM) and what it means for patients, providers and...

PUBLICATIONS Ophthalmology August 13, 2025 Medication insights: teprotumumab-trbw (Tepezza) The U.S. Food and Drug Administration (FDA) first approved teprotumumab-trbw (Tepezza) in January 2020...

Perspectives Oncology Insights: First-in-class bladder cancer therapy and the Bacillus Calmette-Guérin (BCG) shortage Approximately 83,000 new bladder cancer cases are diagnosed in the U.S. in each...

publications Radiopharmaceutical discovery and use is gaining momentum March 14, 2025 Author: Abby Kim, PharmD, BCOP Introducing Abby Kim, PharmD, BCOP Abby Kim, a Board-Certified Oncology...

Oncology Insights: Transformative treatment for small cell lung cancer After decades of research, a new treatment is emerging for this aggressive form of lung cancer. By: Simone Ndujiuba, PharmD,...

Diversity, equity and inclusion Our commitment to diversity, equity and inclusion (DEI) is rooted in our purpose and dedication to serving others. Breadcrumb Home Who we are Culture Diversity,...